Mulmit

Eloxx Pharmaceuticals, Inc.Eloxx Pharmaceuticals, Inc.

ELOX Nasdaq

Annual financials

PeriodRevenueOperating incomeNet incomeEPS
2025-12-310-6,438,000-5,995,000-5.34
2024-12-316,359,000-2,468,000-3,143,000-9.2
2023-12-310-17,288,000-17,054,000-72.98
2014-06-30182,229-9,147,796-9,225,234
2013-06-307,819-4,650,500-6,122,542

Insider filings (Forms 3/4/5)

DateOwnerTitleShares
2026-06-10Domicilium Real Estate Fund III LP238,422
2026-06-10Domicilium Real Estate Fund III LP361,578
2026-06-10Domicilium Real Estate Fund III LP238,422
2026-06-10Domicilium Real Estate Fund III LP361,578
2026-06-10Aggarwal SumitPresident and CEO328,833
2026-06-08Webster Stephen W13,587
2026-06-08Walts Alan Edmund8,590
2026-06-08Kjellson Nina S13,587
2026-06-08Rubin Steven D4,018
2026-05-27Domicilium Real Estate Fund III LP113,636
2026-05-27Domicilium Real Estate Fund III LP113,636
2026-05-27Coastlands Capital LP1,250,000

8-K events

FiledItems
2026-08-11Results of operations · Financial statements and exhibits
2026-06-01Unregistered sales of equity securities · Material modification to rights of security holders · Officer or director change · Amendments to charter or bylaws · Financial statements and exhibits
2026-05-01Submission of matters to a vote
2025-08-12Officer or director change · Financial statements and exhibits
2024-10-17Officer or director change · Financial statements and exhibits
2024-07-16Entry into a material agreement · Creation of a direct financial obligation
2024-03-29Officer or director change
2024-03-14Entry into a material agreement
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…